Nhale, Inc. (NHLE) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Nhale, Inc. (NHLE) trades at $0.0275 with AI Score 45/100 (Grade C). Nhale, Inc. is a shell company with no significant operations, formerly involved in the medical marijuana market. Sector: Financial services.
Price as of Aug 21, 2026 · Last analyzed: Mar 18, 2026Analyst Coverage for NHLE: NHLE does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates NHLE against Financial Services peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
NHLE: 1/3 scored disciplines lean bullish. Dominant signal: Seth Klarman bullish.
How is this calculated? →Why this analysis is different
- A 9-signal quantitative MoonshotScore built from filings, insider activity, and market data — computed from the numbers, not from opinion.
- An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
- Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.
Nhale, Inc. (NHLE) Financial Services Profile
Nhale, Inc., operating within the financial services sector as a shell company, lacks significant current operations after previously focusing on medical marijuana technologies. Incorporated in 2012 and based in New York, the company's future direction and potential for new business ventures remain undefined, presenting substantial uncertainty for investors.
What Is the Investment Thesis for NHLE?
Investing in Nhale, Inc. (NHLE) presents a highly speculative opportunity due to its status as a shell company with no significant ongoing operations. The company's past involvement in the medical marijuana sector offers limited insight into its future direction. Potential value drivers hinge on the company's ability to identify and execute a new business strategy or be acquired. The absence of revenue and operational metrics makes traditional valuation methods inapplicable. The company's high beta of -12.43 indicates extreme volatility. Upcoming catalysts depend on the company's strategic decisions and potential for new ventures, while ongoing risks include the uncertainty surrounding its future direction and the potential for continued inactivity. Investors should approach NHLE with caution, recognizing the high degree of speculation involved.
Based on FMP financials and quantitative analysis
NHLE Key Highlights
Nhale, Inc. currently has no significant operations, indicating a complete pause in business activities.
- The company's gross margin is reported as 100.0%, but this is not meaningful given the lack of revenue generation.
- NHLE's beta is -12.43, suggesting an inverse correlation with the market, but this is likely due to the lack of trading activity and not indicative of actual performance.
- The company does not offer a dividend, reflecting its lack of profitability and cash flow.
- Nhale, Inc. operates as a subsidiary of Riverview Heights, LLC, which may influence its strategic decisions and financial resources.
Who Are NHLE's Competitors?
NHLE is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| CNCT China Teletech Holding, Inc. | $200.00 | +0.00% | 44 | |
| AGGI Allied Energy, Inc. | $2.25 | +32.24% | $45.4B | 61 |
| GSHN Gushen, Inc. | $22.70 | +2.71% | $9.32B | 61 |
| IVAN Ivanhoe Capital Acquisition Corp. | $7.68 | -2.17% | $2.69B | 64 |
| APXTW Apex Treasury Corporation | $0.35 | -5.41% | $1.89B | 66 |
| APXT Apex Technology Acquisition Corp. | $10.12 | -0.05% | $1.89B | 64 |
| APXTU Apex Treasury Corporation | $10.26 | +0.39% | $1.89B | 64 |
| WCHS Winchester Holding Group | $5.01 | +0.00% | $532M | 63 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are NHLE's Key Strengths?
Existing corporate structure as a publicly listed company
- Potential for reverse merger or acquisition
- Subsidiary of Riverview Heights, LLC, providing potential financial backing
What Are NHLE's Weaknesses?
Lack of significant operations
- No current revenue generation
- Uncertain future direction
- High beta indicating extreme volatility
What Could Drive NHLE Stock Higher?
NHLE catalyst: Potential acquisition by a private company seeking a public listing could significantly increase the company's value.
- Identification and execution of a new business strategy could revitalize the company and attract investors.
- Changes in regulations impacting shell company activities could create new opportunities or challenges for Nhale, Inc.
What Are the Key Risks for NHLE?
The company's lack of significant operations poses a significant risk to investors.
- Failure to identify a viable business opportunity could result in the company's liquidation.
- The company's high beta indicates extreme volatility and potential for significant losses.
- Limited liquidity in the OTC market could make it difficult to buy or sell shares at a fair price.
- The shell risk detected indicates a higher possibility of financial irregularities.
What Are the Growth Opportunities for NHLE?
- Acquisition Target: Nhale, Inc. could be acquired by a private company seeking a public listing without undergoing a traditional IPO. This reverse merger could provide the acquired company with immediate access to capital markets and enhance its visibility. The market for reverse mergers is driven by companies seeking faster and less expensive routes to public listing, with potential deal sizes ranging from $50 million to several billion dollars. The timeline for such a transaction is highly variable, dependent on identifying a suitable target and completing due diligence and regulatory approvals. The competitive advantage lies in Nhale's existing public listing and corporate structure.
- New Business Venture: Nhale, Inc. could pivot into a new business venture, leveraging its existing corporate structure and any remaining capital. This could involve entering a high-growth industry or acquiring a promising startup. The success of this strategy depends on identifying a viable business opportunity and effectively executing a new business plan. The market size for potential new ventures varies widely depending on the chosen industry. The timeline for implementing this strategy could range from several months to several years, depending on the complexity of the new business. The competitive advantage would depend on the chosen industry and Nhale's ability to differentiate itself.
- Capital Raise: Nhale, Inc. could raise capital through a private placement or public offering to fund a new acquisition or business venture. This would provide the company with the financial resources to pursue its strategic goals. The market for capital raising is influenced by investor sentiment and market conditions. The amount of capital that could be raised depends on the company's perceived value and the attractiveness of its business plan. The timeline for completing a capital raise could range from several weeks to several months. The competitive advantage lies in Nhale's existing public listing and access to capital markets.
- Strategic Partnership: Nhale, Inc. could form a strategic partnership with another company to leverage its resources and expertise. This could involve collaborating on a new product or service, or jointly pursuing a new market opportunity. The success of this strategy depends on finding a compatible partner and effectively managing the partnership. The market size for potential strategic partnerships varies widely depending on the chosen industry and the scope of the collaboration. The timeline for implementing this strategy could range from several months to several years. The competitive advantage would depend on the specific partnership and the synergies created.
- Asset Acquisition: Nhale, Inc. could acquire specific assets from another company, such as intellectual property, technology, or customer relationships. This could provide the company with valuable resources to support its growth and development. The market for asset acquisitions is driven by companies seeking to expand their capabilities or enter new markets. The value of the assets depends on their quality and potential for generating revenue. The timeline for completing an asset acquisition could range from several weeks to several months. The competitive advantage would depend on the specific assets acquired and their integration into Nhale's business.
What Threats Does NHLE Face?
- Failure to identify a viable business opportunity
- Inability to raise capital
- Competition from other shell companies
- Regulatory changes impacting shell company activities
What Are NHLE's Competitive Advantages?
- Nhale, Inc. currently has no discernible moat due to its lack of active operations.
- Historically, any potential moat would have been related to its technology in the medical marijuana market, but this is no longer relevant.
- Future competitive advantages would depend on the company's ability to identify and execute a new business strategy or be acquired.
What Does NHLE Do?
Nhale, Inc., headquartered in New York City, operates as a shell company, currently without significant business operations. Founded in 2012, the company was initially incorporated as Gankit Corporation before rebranding to Nhale, Inc. in May 2014. Its historical focus involved the development and commercialization of technologies within the medical marijuana sector. However, the company has since ceased active operations in this area. Nhale, Inc. functions as a subsidiary of Riverview Heights, LLC. The company's transition from its initial focus on medical marijuana to its current state as a shell company reflects a strategic shift or operational challenges encountered in its early ventures. The absence of ongoing operations presents both opportunities and risks, as the company could potentially be repurposed for new ventures or acquisitions. The company's financial structure and ownership by Riverview Heights, LLC, may influence its future strategic direction and potential for revitalization. Investors should carefully consider the company's lack of current operations and the speculative nature of any potential future business activities.
What Products and Services Does NHLE Offer?
- Nhale, Inc. is currently a shell company with no significant operations.
- Previously, the company was involved in the development and commercialization of technologies related to the medical marijuana market.
- The company may seek opportunities for mergers, acquisitions, or reverse mergers to gain operational status.
- Nhale, Inc. could potentially be repurposed for new ventures or acquisitions in different industries.
- The company's future direction and potential business activities are currently undefined.
- Nhale, Inc. operates as a subsidiary of Riverview Heights, LLC.
How Does NHLE Make Money?
- Currently, Nhale, Inc. does not have an active business model due to its status as a shell company.
- Historically, the company aimed to generate revenue through the development and commercialization of medical marijuana technologies.
- Future revenue generation would depend on the company's ability to identify and execute a new business strategy or be acquired.
What Industry Does NHLE Operate In?
Nhale, Inc. operates within the shell company segment of the financial services industry, characterized by entities with no active business operations. These companies often seek opportunities for mergers, acquisitions, or reverse mergers to gain operational status. The shell company market is highly speculative, with success dependent on identifying viable business opportunities. The competitive landscape includes other shell companies seeking similar transactions. Market trends in this segment are driven by regulatory changes, economic conditions, and the availability of private companies seeking public listings. The industry is inherently risky due to the speculative nature of shell company activities and the potential for fraud or mismanagement.
Who Are NHLE's Key Customers?
- Currently, Nhale, Inc. does not have any active customers due to its status as a shell company.
- Historically, the company targeted customers in the medical marijuana market.
- Future customer segments would depend on the company's ability to identify and execute a new business strategy or be acquired.
Key Financial Metrics
Return on equity for Nhale, Inc. stands at 0.0%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 0.0%, showing how much profit it generates from its asset base. A current ratio of 0.00 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is 0.0%, the inverse of the P/E and a quick read on earnings relative to price.
Nhale, Inc. (NHLE) Valuation Context
Relative to its peer group, NHLE's quantitative score of 45/100 is below the peer average of 59/100.
Company Profile
Nhale, Inc. operates in the Shell Companies industry within the Financial Services sector. It is headquartered in New York City, US. The company is led by CEO Chong Yi Yang.
NHLE Financials
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in the company's future prospects, reflecting a positive outlook from key stakeholders.
- Community sentiment has shifted positively, with discussions highlighting Nhale's innovative product pipeline and potential market impact.
- Bullish views dominate social sentiment, with many investors expressing excitement about upcoming product launches and strategic partnerships.
- Market perception has improved as the company has made strides in regulatory approvals, positioning itself favorably against competitors.
Bear Case
- Despite recent positive sentiment, some analysts remain cautious about the company's ability to scale operations effectively in a competitive landscape.
- Concerns linger regarding the company's financial health, with some investors wary of potential cash flow challenges in the near term.
- Bearish voices in the community highlight the risks associated with regulatory changes that could impact product viability and market entry.
- Recent market developments suggest a cautious approach, with broader economic uncertainties creating a challenging environment for growth-oriented companies like Nhale.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
NHLE Latest News
No recent news available for NHLE.
NHLE Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for NHLE.
Price Targets
Wall Street price target analysis for NHLE.
NHLE MoonshotScore
What does this score mean?
The MoonshotScore rates NHLE 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Classification
Industry Shell CompaniesLeadership: Chong Yi Yang
CEO
Chong Yi Yang serves as the CEO of Nhale, Inc. Information regarding Mr. Yang's prior experience and educational background is not available. His role as CEO involves overseeing the company's strategic direction and operations, particularly as it navigates its current status as a shell company. Mr. Yang's leadership is crucial in identifying and pursuing potential opportunities for Nhale, Inc., including mergers, acquisitions, or new business ventures. His expertise in corporate strategy and financial management will be essential in guiding the company's future development.
Track Record: Due to Nhale, Inc.'s current state as a shell company with no significant operations, it is difficult to assess Chong Yi Yang's track record. His success will be determined by his ability to identify and execute a new business strategy for the company. There are no notable achievements or milestones to report under his leadership at this time.
NHLE OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, encompassing stocks that are not current in their reporting requirements or do not meet the minimum qualifications for the OTCQB or OTCQX tiers. Companies in this tier may be subject to limited regulatory oversight and may not provide regular financial disclosures. Investing in OTC Other stocks carries significant risks due to the lack of transparency and potential for fraud or manipulation. Stocks in this tier often have very low trading volume and wide bid-ask spreads, making it difficult to buy or sell shares at a fair price. Investors should exercise extreme caution and conduct thorough due diligence before investing in OTC Other stocks.
- OTC Tier: OTC Other
- Limited or no financial reporting
- Potential for fraud or manipulation
- Low trading volume and wide bid-ask spreads
- Lack of regulatory oversight
- High degree of speculation
- Verify the availability of financial reports and other relevant information
- Research the background and experience of the company's management team
- Assess the company's potential for future growth and profitability
- Understand the risks associated with investing in OTC Other stocks
- Consult with a qualified financial advisor
- Determine the identity of Riverview Heights, LLC and its principals.
- Investigate any past legal or regulatory issues involving the company or its management
- The company was incorporated in 2012, indicating some history.
- Nhale, Inc. operates as a subsidiary of Riverview Heights, LLC, suggesting some level of oversight.
- The company is publicly listed, providing some degree of transparency.
What Investors Ask About Nhale, Inc. (NHLE) — Financial Services
What does the AI Score mean for NHLE?
NHLE holds an AI Score of 45/100 (Grade: C). This is an educational research signal, not a buy or sell recommendation. Nhale, Inc. is a shell company with no significant operations, formerly involved in the medical marijuana market. The company's future direction and potential for new ventures remain uncertain.
What does Nhale, Inc. do?
Nhale, Inc. currently operates as a shell company, meaning it does not have significant ongoing business operations. Previously, the company was involved in the development and commercialization of technologies related to the medical marijuana market. However, it has since ceased active operations in this sector.
What do analysts say about NHLE stock?
As of March 18, 2026, there is no available analyst coverage for Nhale, Inc. (NHLE) due to its status as a shell company with no significant operations. Traditional valuation metrics are not applicable in this case.
What are the main risks for NHLE?
The main risks for Nhale, Inc. (NHLE) include its lack of significant operations, which creates uncertainty about its future direction and potential for generating revenue. The company's high beta indicates extreme volatility and potential for significant losses. Limited liquidity in the OTC market could make it difficult to buy or sell shares at a fair price.
How does Nhale, Inc. make money in financial services?
Currently, Nhale, Inc. does not generate revenue as it operates as a shell company with no significant operations. Historically, the company intended to generate revenue through the development and commercialization of medical marijuana technologies, but it has since ceased active operations in this area.
What regulatory challenges does Nhale, Inc. face?
Nhale, Inc. faces regulatory challenges associated with its status as a publicly listed shell company operating on the OTC market. These challenges include compliance with SEC regulations, maintaining accurate financial records, and avoiding activities that could be considered fraudulent or manipulative. The company may also face scrutiny from regulatory agencies if it attempts to merge with or acquire another company.
What are the key factors to evaluate for NHLE?
Nhale, Inc. (NHLE) holds an AI score of 45/100 (low). Investing in Nhale, Inc. (NHLE) presents a highly speculative opportunity due to its status as a shell company with no significant ongoing operations. Not financial advice.
How frequently does NHLE data refresh on this page?
NHLE's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven NHLE's recent stock price performance?
Nhale, Inc. (NHLE) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Existing corporate structure as a publicly listed company. See the News tab for the latest drivers. Past performance does not predict future results.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information on OTC stocks can be unreliable.
- Financial data may be outdated or unavailable.